Skip to main content

WELCOME

CAMP PODS is a webinar series, consisting of nine one-hour sessions that will take place from February to November 2024 on the 1st Thursday of each month.

The goal of this series is to build a strong Oncology Laboratory Medicine community, where best practices and common challenges can be discussed.  Insights gained will be key to implement across Canada and will help streamline laboratory workflows and practice for laboratory medicine, the end result of which will be improvements in the patient journey.

Overall Learning Objectives:

By the end of the webinar series, an audience member will:

  1. Establish a strong Oncology Education Network
  2. Compare ideas, thoughts and common challenges
  3. Identify gaps and find team solutions for improving patient care
  4. Integrate pathology and oncology practices

OUR NEXT CAMP PODS SESSION – POSTPONED

Thursday, September 5th, 2024
10:00am – 10:45am PST Molecular Pathology of Ovarian Cancer – The Central Role of Pathologist Frederique Penault-Llorca,, MD, PhD
Professor of Pathology
Centre Jean Perrin
Université Clermont Auvergne, Clermont-Ferrand, France
10:45am  – 11:00am PST Questions & Answers
Learning objectives:
By the end of this presentation, participants will be:

  1. Explain the biology of high-grade serous ovarian carcinoma and the implication for Parpi
  2. Describe the development of molecular tests for HDR testing
  3. Discuss the role of molecular diagnosis for the characterization of rare ovarian tumors

OUR LAST CAMP PODS SESSION

Thursday, August 15th, 2024
10:00am – 10:45am PST Molecular Aspects of Thyroid Pathology Dr. Vania Nosé, M.D., Ph.D
Professor of Pathology – Harvard Medical School
Pathologist and Consultant, Endocrine Pathology
Massachusetts General Hospital
Boston, MA
10:45am  – 11:00am PST Questions & Answers
Learning objectives:
By the end of this presentation, participants will be:

  1. Indicate the newly implemented WHO terminology of thyroid lesions associated with gene alterations.
  2. Illustrate familial syndromes involving thyroid: from genetic cancer susceptibility to newly established endocrine syndromes.
  3. Recall classical thyroid findings in PTEN hamartoma tumour syndrome/Cowden disease.
  4. Identify diverse pathological findings of DICER1-related thyroid tumours.